Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026.

The company will take part in a fireside chat beginning at 9:50 a.m. ET.

Investors and the general public are invited to listen to the session by visiting http://investor.bms.com. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  258.83
-4.21 (-1.60%)
AAPL  271.26
+1.09 (0.40%)
AMD  347.61
+10.50 (3.11%)
BAC  53.45
+0.56 (1.07%)
GOOG  372.61
+25.30 (7.28%)
META  605.75
-63.37 (-9.47%)
MSFT  404.03
-20.43 (-4.81%)
NVDA  201.37
-7.88 (-3.77%)
ORCL  162.28
-1.56 (-0.95%)
TSLA  377.06
+4.25 (1.14%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.